Sanofi is Committed to Continuing the Tradition of Excellence with our Established Insulin Portfolio
Sanofi’s dedication to insulin therapy supports the diverse needs of both healthcare providers and their patients.
- Wide range of products
- Educational resources
- Industry-recognized* supply chain
- Patient support programs
- Copay and coverage programs
*As per Gartner. Gartner announces 2025 rankings of the Global Supply Chain Top 25. Gartner, Inc; June 18 2025. https://www.gartner.com/en/newsroom/2025-06-18-gartner-announces-2025-rankings-of-the-global-supply-chain-top-25. Accessed 20 October, 2025.
Insulin Products
MERILOG™ (insulin aspart-szjj) injection 100 Units/mL
SOLIQUA® 100/33 (insulin glargine and lixisenatide) injection 100 Units/mL and 33 mcg/mL
Our Commitment
Sanofi's dedication to insulin therapy spans over a century, continually evolving to provide various treatment options.
Order Samples & Resources
Sanofi is committed to supporting healthcare providers with samples of our insulin products to help you evaluate their suitability for your practice and patients.
Financial Assistance
Our insulins are capped at $35 per month and various savings and coverage information is widely available to help reduce barriers to access.
Patient Resources & Tools
Sanofi has a dedicated website designed to foster a stronger connection with patients. It offers a wealth of educational resources and valuable information tailored to help meet their needs.
